Gene therapy overcomes mutation problems in cystic fibrosis

Gene therapy overcomes mutation problems in cystic fibrosis

A team of researchers affiliated with multiple institutions in Germany has developed a type of gene therapy that could be used to help people with cystic fibrosis. In their paper published in the journal Nature Nanotechnology, the group describes how they developed a new class of non-viral gene vectors that could be used to reduce symptoms of cystic fibrosis.

Prior research has shown that CF is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, which leads to problems with chloride channels. In this new effort, the researchers developed a non-viral gene vector that they used to insert healthy copies of CFTR into the DNA of epithelial cells (where the mucus is produced), which restored functionality of the defective chloride channels. The researchers carried out their work using transposases via a synthetically produced messenger RNA that was delivered to test mice using an inhalant.

Testing on mice showed increased expression of a CFTR protein in respiratory cells, which, the researchers noted, was long-lasting. The overall results were improvements in chloride channel function and a reduction in the production of thick mucus, presumably leading to reduced risk from infections and longer life spans. The researchers note that their work is far enough along to begin conducting clinical trias to see if the approach would work as well in human patients. They also note that their approach could very well be used to help treat other rare lung diseases.

The research team has been awarded the Adolf Windorfer Prize 2021 for their work, which in addition to recognizing outstanding work in research involved cystic fibrosis, also comes with 5,000 euros in prize money.

 

Source:  medicalxpress.com

Ellen Chamberlain

Ellen Chamberlain is from Arlington VA and has always been interested in figuring out new things and that led them to science reporting. Ellen researches and reports on new tech and AI related news. She also enjoys video games and reading.